Results 181 to 190 of about 288,284 (303)

Hamman-Rich Syndrome with Encephalitis, Hepatosplenomegaly, Anaemia and Thrombocytopenia [PDF]

, 1965
J H Liebeschuetz, N. R. Butler
openalex   +1 more source

Maternal Immune Thrombocytopenic Purpura Leading to Severe Neonatal Autoimmune Thrombocytopenia: Report of Two Cases

National Board of Examinations Journal of Medical Sciences
Introduction: In neonatal intensive care units, neonatal thrombocytopenia is one of the common hematological abnormality seen. Neonatal autoimmune thrombocytopenia should be considered in any neonate who is born to a known case of immune thrombocytopenia
Khushwant Kaur, Varughese PV, Nidhie Shajan   +2 more
doaj   +1 more source

Therapeutic targeting of chromatin alterations in leukemia and solid tumors

International Journal of Cancer, EarlyView.
Abstract Alterations in chromatin conformation and post‐translational modification of histones have become increasingly recognized as critical drivers of cancer development, progression, and therapy resistance. Recent advances in drug development have led to the establishment of several highly selective small molecule inhibitors, several of which are ...
Florian Perner, Tobias Berg, Daniel Sasca, Sophie‐Luise Mersiowsky, Jayant Y. Gadrey, Johanna Thomas, Michael W. M. Kühn, Michael Lübbert   +7 more
wiley   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Evaluating the ability of fullPIERS calculator to predict adverse maternal outcomes in pre‐eclampsia at Charlotte Maxeke Johannesburg Academic Hospital

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To evaluate the ability of the fullPIERS model to predict adverse maternal outcomes in patients diagnosed as early‐onset pre‐eclampsia at Charlotte Maxeke Johannesburg Academic Hospital, South Africa. Methods Retrospective record review and analysis of 134 patients admitted with early‐onset pre‐eclampsia.
Thomas Matonhodze, Robert Nyakoe
wiley   +1 more source

Systemic therapy‐based split‐course stereotactic body radiation therapy

Precision Radiation Oncology, Volume 6, Issue 4, Page 306-320, December 2022., 2022
Abstract Purpose Given the therapeutic toxicity of concurrent chemoradiotherapy, the dose of chemotherapy is always limited. Hence, the question of how to administer adequate chemotherapy to synchronize stereotactic body radiation therapy (SBRT) treatment strategy for maximizing the benefits of neoadjuvant therapy to improve prognosis is a challenging ...
Rong Zheng, Bisi Wang, Feihong Liang, Benhua Xu   +3 more
wiley   +1 more source

The association between additional radiotherapy after systemic chemotherapy and the prognosis of stage FIGO 2018 IVB cervical cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective Systemic platinum‐based chemotherapy is the first‐line treatment of choice for metastatic cervical cancer. While subsequent radiotherapy after primary chemotherapy is a potential option, its benefit remains unclear. This multicenter retrospective study aimed to evaluate whether post‐chemotherapy radiotherapy improves the prognosis of
Ai Miyoshi, Fumiaki Isohashi, Makoto Fujii, Tadashi Iwamiya, Masahiko Takemura, Yoshikazu Nagase, Takeshi Yokoi, Emi Yoshioka, Kimihiko Ito, Eri Yamabe, Kanji Masuhara, Tomoko Tsujie, Tadashi Kimura, Michiko Kodama   +13 more
wiley   +1 more source

Bacteriuria profile and antimicrobial sensitivity among pregnant women attending antenatal care at Jazan and Sabyia general hospitals, Jazan Region, KSA: A cross‐sectional study

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Background Bacteria in urine, which is known as bacteriuria, is divided clinically into two types: symptomatic, where the patient experiences urinary complaints, and asymptomatic (ASB), in which the patient has no complaints. Pregnant women who have ASB may later develop symptomatic urinary tract infection, which is considered one of the most ...
Isameldin Elamin Medani, Ahlam Hakami, Ahmed Altraifi, Maha Murtada Abdelmageed, Ali Khormi, Uma Chourasia, Essam Falagy, Ahmad Alnamy, Bishi Moukli, Sarah Mnaa, Maha Alanazi, Manal Jamali, Ali Maashi, Hayat Khudhayr, Sara Eltigani, Nouf Shahhar, Safia Muqri, Nada Makein, Yasser Majrabi   +18 more
wiley   +1 more source

FIGO guideline on liver disease and pregnancy

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract The number of women entering pregnancy with chronic liver disease is rising. Gestational liver disorders affect 3% of the pregnant population. Both can be associated with significant maternal and fetal morbidity and mortality. European guidance has recently been published to inform management.
Melanie Nana, Virna Medina, Cynthia Maxwell, Ciara McCormick, Gloria Taliani, Ulrich Beuers, Deborah Money, Bo Jacobsson, Anil Kapur, Titus Beyuo, Francisco Ruiloba, Graeme Smith, Lina Bergman, Sharleen O'Reilly, Patrick O'Brien, Mark Hanson, Mary Rosser, Claudio Sosa, Sumaiya Adam, Valerie Guinto, Liona Poon, Fionnuala McAuliffe, Catherine Williamson, on behalf of the FIGO Committee on Impact of Pregnancy on Long‐term Health, FIGO Committee on Infections during Pregnancy and the FIGO Division of Maternal and Newborn Health   +24 more
wiley   +1 more source

Pembrolizumab Plus Lenvatinib for Metastatic Renal Cell Carcinoma in a Patient on Hemodialysis

IJU Case Reports, EarlyView.
ABSTRACT Introduction There is no clear evidence of the safety and efficacy of pembrolizumab plus lenvatinib combination therapy in patients on hemodialysis. This is the first report of a patient on hemodialysis to receive this combination therapy for metastatic renal cell carcinoma.
Shimpei Yamashita, Hiroki Kawabata, Yuya Iwahashi, Satoshi Muraoka, Takahito Wakamiya, Fumiyoshi Kojima, Yasuo Kohjimoto, Shin‐ichi Murata, Isao Hara   +8 more
wiley   +1 more source